Vhh's require neither disulfide bonds nor glycosylation for stability; they are remarkably thermostable as well. By immunizing an alpaca with cytoplasmic proteins from the organism of interest, a representative set of such Vhh's will be generated and isolated by means of selective amplification of the Vhh sequences present by PCR, followed by expression of the Vhh's as a library in phage display mode. At the C-terminus of each Vhh, the phage expression vectors carry a recognition motif for sortase, a bacterial enzyme that allows quantitative and site-specifi modification of proteins of interest, including Vhh's. Sortases recognize an LPXTG motif, and cleave between the Thr and Gly residues with concomitant formation of a thioacyl intermediate. Short synthetic peptides, modified according to need with fluorophores, biotin or combinations of thereof, resolve this thioacyl intermediate and allow covalent, near-quantitative and site-specificinstallation of such probes at the site of sortase cleavage, without inflicting chemical damage on the Vhh antigen combining site. This allows the rapid production of Vhh's that are affinity tagged with biotin. They can be used directly for retrieval of the target antigen to facilitate its identification by affinity purification and proteomic (LC/MS/MS) analysis. Indeed, this unbiased approach has been successfully reduced to practice in a trial run in the applicant's laboratory, leading to the isolation of a high affinity Vhh that recognizes murine class II MHC products, starting from a library constructed from an alpaca immunized with unfractionated mouse splenocytes. The next targets envisioned are components of the yeast nuclear pore, available in mg amounts. While some yeast work has been performed in the applicant's laboratory, the proposed project presents the first serious foray into yeast cell biology, but with obvious extensions into multicellular eukaryotes. A key element to the approach is the lack of a requirem
The ability to perturb protein-protein interactions inside cells on a large scale (with the specificity afforded by antigen-antibody interactions) is a new tool to analyze host cell biology in a manner not previously possible. If applied on a large scale; as proposed here; this technology should be considered a complement to genetics and RNA-interference based approaches. This project will provide a new window on the biology of the eukaryotic cell and thus illuminate new aspects of normal physiology and aberrations in disease.
| Ju, Chia-Hsin; Blum, Lisa K; Kongpachith, Sarah et al. (2018) Plasmablast antibody repertoires in elderly influenza vaccine responders exhibit restricted diversity but increased breadth of binding across influenza strains. Clin Immunol 193:70-79 |
| Orlova, Darya Y; Meehan, Stephen; Parks, David et al. (2018) QFMatch: multidimensional flow and mass cytometry samples alignment. Sci Rep 8:3291 |
| Ingram, Jessica R; Blomberg, Olga S; Rashidian, Mohammad et al. (2018) Anti-CTLA-4 therapy requires an Fc domain for efficacy. Proc Natl Acad Sci U S A 115:3912-3917 |
| Chen, Guan-Yu; Li, Zeyang; Duarte, Joao N et al. (2017) Rapid capture and labeling of cells on single domain antibodies-functionalized flow cell. Biosens Bioelectron 89:789-794 |
| Van Elssen, Catharina H M J; Rashidian, Mohammad; Vrbanac, Vladimir et al. (2017) Noninvasive Imaging of Human Immune Responses in a Human Xenograft Model of Graft-Versus-Host Disease. J Nucl Med 58:1003-1008 |
| Rashidian, Mohammad; Ingram, Jessica R; Dougan, Michael et al. (2017) Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells. J Exp Med 214:2243-2255 |
| Ingram, Jessica R; Blomberg, Olga S; Sockolosky, Jonathan T et al. (2017) Localized CD47 blockade enhances immunotherapy for murine melanoma. Proc Natl Acad Sci U S A 114:10184-10189 |
| Truttmann, Matthias C; Ploegh, Hidde L (2017) rAMPing Up Stress Signaling: Protein AMPylation in Metazoans. Trends Cell Biol 27:608-620 |
| Fang, Tao; Van Elssen, Catharina H M J; Duarte, Joao N et al. (2017) Targeted antigen delivery by an anti-class II MHC VHH elicits focused ?MUC1(Tn) immunity. Chem Sci 8:5591-5597 |
| Ingram, Jessica R; Dougan, Michael; Rashidian, Mohammad et al. (2017) PD-L1 is an activation-independent marker of brown adipocytes. Nat Commun 8:647 |
Showing the most recent 10 out of 39 publications
